| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.47 | 4e-39 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.57 | 3e-33 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.38 | 2e-26 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.51 | 1e-17 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.31 | 1e-17 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.29 | 5e-15 |
| mRNA | canertinib | CTRPv2 | pan-cancer | AAC | 0.26 | 8e-12 |
| mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.29 | 7e-11 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.35 | 8e-10 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.19 | 1e-07 |